Swedish Orphan Biovitrum : 22 March – Phase 3 study r

You efficacy and point and we're highly statistically significant, which of course is the first thing.


0:0:6.780 --> 0:0:37.30


Peter... | March 27, 2023

Related Keywords

London , City Of , United Kingdom , Anders Ullman , Thomas Kudsk Larsen , Tania Gonzalez Rivera , Peter Traber , Deutsche Bank , Ullman Tolerability , Kudsk Larsen Can , Kudsk Larsen You , Swedish Orphan Biovitrum Ab Publ Stock Exchange , News , Information , Press Release , You , Efficacy , End , Joint , Ighly , Statistically , Which , F , Course , Us , The , Irst Sobi Se0000872095 ,